drugset
drugset / Trial / NCT00138749

An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

NCT00138749 ↗

Phase 2 Completed 402 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.

Timeline

Start
2004-11
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Reboxetine Unknown — —

Indications

female stress incontinence